Home › Funds › DUPONT CAPITAL MANAGEMENT CORP › LIMNW

DUPONT CAPITAL MANAGEMENT CORP position in LIMNW

LIMINATUS PHARMA INC. · Materials

DUPONT CAPITAL MANAGEMENT CORP reported holding 6,250 shares of LIMNW (LIMINATUS PHARMA INC.) in its Q3 2026 13F filing — a position valued at US$341K, representing 0.02% of its reported portfolio and ranking #25 among its reported holdings. DUPONT CAPITAL MANAGEMENT CORP has disclosed LIMNW holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)6.25K sh
Reported value held$341.00K
Portfolio Weight0.02%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DUPONT CAPITAL MANAGEMENT CORP's LIMNW position evolved

DUPONT CAPITAL MANAGEMENT CORP first disclosed a stake in LIMNW in Q2 2025 at 6,250 shares (US$2K). The position peaked in Q3 2026 at 6,250 shares, worth US$341K. Across 6 filings, DUPONT CAPITAL MANAGEMENT CORP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,250 shares valued at US$341K.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 6.25K $1.52K New
Q3 2025 6.25K $925 Hold
Q4 2025 6.25K $219 Hold
Q1 2026 6.25K $306 Hold
Q2 2026 6.25K $318.00K Hold
Q3 2026 6.25K $341.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LIMNW and 13F data

LIMNW (LIMINATUS PHARMA INC.) is a Materials company. 24 other funds we track also report a position in LIMNW — the largest reported positions include Arena Capital Advisors, LLC- CA (US$2K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LIMNW

All LIMNW fund holders →

FAQ

How long has DUPONT CAPITAL MANAGEMENT CORP held LIMNW?

DUPONT CAPITAL MANAGEMENT CORP has disclosed LIMNW holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is DUPONT CAPITAL MANAGEMENT CORP's current position in LIMNW?

As of Q3 2026, DUPONT CAPITAL MANAGEMENT CORP holds 6.25K shares of LIMNW (LIMINATUS PHARMA INC.), valued at $341.00K, representing 0.02% of its reported portfolio and ranking #25.

Has DUPONT CAPITAL MANAGEMENT CORP been buying or selling LIMNW?

In the latest 13F filing (Q3 2026), DUPONT CAPITAL MANAGEMENT CORP held unchanged its position in LIMNW. The position peaked in Q3 2026 at 6.25K shares.

Which other funds hold LIMNW?

Other major institutional holders of LIMNW include Arena Capital Advisors, LLC- CA, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.